Line 84: | Line 84: | ||
</li> | </li> | ||
<li> | <li> | ||
− | <a href="https://2018.igem.org/Team:Bielefeld-CeBiTec/Toxicity_Results"> | + | <a href="https://2018.igem.org/Team:Bielefeld-CeBiTec/Toxicity_Results">Toxicity Results</a> |
</li> | </li> | ||
<li> | <li> | ||
− | <a href="https://2018.igem.org/Team:Bielefeld-CeBiTec/Accumulation_Results"> | + | <a href="https://2018.igem.org/Team:Bielefeld-CeBiTec/Accumulation_Results">Accumulation Results</a> |
</li> | </li> | ||
<li> | <li> | ||
− | <a href="https://2018.igem.org/Team:Bielefeld-CeBiTec/siRNA_Results"> | + | <a href="https://2018.igem.org/Team:Bielefeld-CeBiTec/siRNA_Results">Silencing Results</a> |
</li> | </li> | ||
<li> | <li> | ||
− | <a href="https://2018.igem.org/Team:Bielefeld-CeBiTec/Ferritin_Results"> | + | <a href="https://2018.igem.org/Team:Bielefeld-CeBiTec/Ferritin_Results">Nanoparticles Results</a> |
</li> | </li> | ||
<li> | <li> |
Latest revision as of 03:20, 18 October 2018